{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:36:23Z","timestamp":1791081383382,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T00:00:00Z","timestamp":1297209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt C"],"published-print":{"date-parts":[[2011,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Creatine is a nitrogen containing compound that serves as an energy shuttle between the mitochondrial sites of ATP production and the cytosol where ATP is utilized. There are two known disorders of creatine synthesis (both transmitted as autosomal recessive traits: arginine: glycine amidinotransferase (AGAT) deficiency; OMIM 602360; and guanidinoacetate methyltransferase (GAMT) deficiency (OMIM 601240)) and one disorder of creatine transport (X\u2010linked recessive SLC6A8 creatine transporter deficiency (OMIM 300036)). All these disorders are characterized by brain creatine deficiency, detectable by magnetic resonance spectroscopy. Affected patients can have mental retardation, hypotonia, autism or behavioral problems and seizures. The diagnosis of these conditions relies on the measurement of plasma and urine creatine and guanidinoacetate. Creatine levels in plasma are reduced in both creatine synthesis defects and guanidinoacetate is increased in GAMT deficiency. The urine creatine\/creatinine ratio is elevated in creatine transporter deficiency with normal plasma levels of creatine and guanidinoacetate. The diagnosis is confirmed in all cases by DNA testing or functional studies. Defects of creatine biosynthesis are treated with creatine supplements and, in GAMT deficiency, with ornithine and dietary restriction of arginine through limitation of protein intake. No causal therapy is yet available for creatine transporter deficiency and supplementation with the guanidinoacetate precursors arginine and glycine is being explored. The excellent response to therapy of early identified patients with GAMT or AGAT deficiency candidates these condition for inclusion in newborn screening programs. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.c.30292","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T21:28:34Z","timestamp":1297286914000},"page":"72-78","source":"Crossref","is-referenced-by-count":88,"title":["Disorders of creatine transport and metabolism"],"prefix":"10.1002","volume":"157","author":[{"given":"Nicola","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Ardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Vanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"e_1_2_4_2_1","first-page":"1S","article-title":"Newborn screening: toward a uniform screening panel and system","volume":"8","author":"Rinaldo P","year":"2006","journal-title":"Genet Med"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33551"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2007.07.010"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.01.043"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00175-0"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-008-0125-5"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200004)47:4<511::AID-ANA15>3.0.CO;2-N"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.27.061406.093621"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0162-9"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.10.008"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.06.021"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.04.005"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0902-1"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(95)80155-F"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(86)90385-1"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32477-8"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.12.3373"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)80394-3"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.09.031"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-213X-9-39"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4781(95)00184-0"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9238"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/323765"},{"key":"e_1_2_4_25_1","first-page":"58","article-title":"The second family with AGAT deficiency (creatine biosynthesis defect): diagnosis, treatment and the first prenatal diagnosis","volume":"1","author":"Johnston K","year":"2005","journal-title":"Am Soc Hum Genet"},{"key":"e_1_2_4_26_1","first-page":"3S89","article-title":"Inborn errors of creatine metabolism and epilepsy: clinical features, diagnosis, and treatment","volume":"17","author":"Leuzzi V","year":"2002","journal-title":"J Child Neurol"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000239153.39710.81"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)71316-5"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.12.020"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000234852.43688.bf"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-200508000-00003"},{"key":"e_1_2_4_32_1","article-title":"The screening of SLC6A8 deficiency among Estonian families with X\u2010linked mental retardation","author":"Puusepp H","year":"2008","journal-title":"J Inherit Metab Dis."},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/422102"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/320595"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024405821638"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0230424100"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh112"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022443503883"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6486-9_9"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000230152.25203.01"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2744(80)90194-1"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80186-5"},{"key":"e_1_2_4_43_1","first-page":"914","article-title":"Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man","volume":"58","author":"Stockler S","year":"1996","journal-title":"Am J Hum Genet"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6486-9_8"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2009.02.003"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2005.04.022"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2810021"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.3.1107"}],"container-title":["American Journal of Medical Genetics Part C: Seminars in Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.c.30292","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.c.30292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:43:32Z","timestamp":1694447012000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.c.30292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2,15]]}},"alternative-id":["10.1002\/ajmg.c.30292"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.c.30292","archive":["Portico"],"relation":{},"ISSN":["1552-4868","1552-4876"],"issn-type":[{"value":"1552-4868","type":"print"},{"value":"1552-4876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]}}}